Daniel R. Chard - Feb 21, 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Feb 21, 2023
Transactions value $
-$209,288
Form type
4
Date filed
2/22/2023, 08:57 PM
Previous filing
May 11, 2022
Next filing
May 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability -$209K -1.82K -11.39% $115.31 14.1K Feb 21, 2023 Direct F1, F2
holding MED Common Stock 109K Feb 21, 2023 The Dan and Allyson Family Irrevocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld to satisfy the tax withholding obligations upon vesting of an equity award.
F2 This equity award vested on February 19, 2023, which fell on a weekend. The price used for the withholding was the closing sales price for the most recent trading day prior to the vesting date.
F3 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.